← Back to Search

Project PEER: Understanding the Lung Cancer Patient ExperiEnce (PEER Trial)

Verified Trial

N/A

Recruiting

Led By Upal Basu Roy, PhD, MPH

Research Sponsored by LUNGevity Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Adults with self-reported lung cancer diagnosis or caregiver of someone with a self-reported lung cancer diagnosis (patient has to be alive)

* Ability to read and answer questions in English

Timeline

Screening 0 days

Treatment 12 months

Follow Up 0 days

Awards & highlights

No Placebo-Only Group

Summary

This trial seeks to learn how treatments for lung cancer affect quality of life. Join by emailing study team to get access to the study website & get an e-gift card each month for 12 months for completing surveys. #LungCancer #Participation #ResearchStudy

Who is the study for?

This study is for individuals with lung cancer, including those with a specific type called lung carcinoid tumor, as well as their caregivers. Participants should be willing to share their experiences through monthly online surveys over the course of a year.

What is being tested?

There are no medical treatments being tested in this trial. Instead, participants will complete online surveys designed to gather information on how living with lung cancer affects quality of life from both patients' and caregivers' perspectives.

What are the potential side effects?

Since there are no medical interventions involved in this study, there are no side effects associated with treatment. The main consideration for participants is the time commitment required to complete the monthly surveys.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 0 days0 visits

Treatment ~ 12 months0 visits

Follow Up ~ 0 days0 visits

Screening ~ 0 days

Treatment ~ 12 months

Follow Up ~0 days

This trial's timeline: 0 days for screening, 12 months for treatment, and 0 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Explore guideline concordant care

Explore impacts of different classes of therapies

Explore patient-reported functioning, symptoms, side effects and overall quality of life

Other study objectives

Impact of the pandemic on access to treatment

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: PatientsExperimental Treatment1 Intervention

Individuals who have been diagnosed with lung cancer. Individuals with all stages of lung cancer and individuals who have reached no evidence of disease (NED).

Group II: CaregiversExperimental Treatment1 Intervention

Family and friends who provide care for someone who has been diagnosed with lung cancer

0 / 3Eligibility criteria met